|
GB9816837D0
(en)
*
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
AU3653099A
(en)
|
1998-04-17 |
1999-11-08 |
Parker Hughes Institute |
Btk inhibitors and methods for their identification and use
|
|
BR9912729A
(pt)
*
|
1998-08-04 |
2001-05-02 |
Astrazeneca Ab |
Derivado de amida, processo para prepará-lo, e, uso do mesmo
|
|
ATE254105T1
(de)
*
|
1998-09-25 |
2003-11-15 |
Astrazeneca Ab |
Benzamid-derivate und ihre verwendung als cytokine inhibitoren
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
EP1434579B1
(en)
|
2001-10-09 |
2011-06-08 |
Amgen Inc. |
Imidazole derivatives as antiinflammatory agents
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
JP4896518B2
(ja)
|
2002-12-13 |
2012-03-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
ニコチンアミド系キナーゼ阻害薬
|
|
TW200616974A
(en)
*
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200634003A
(en)
*
|
2004-12-22 |
2006-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
AR053992A1
(es)
*
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
KR100919905B1
(ko)
|
2005-01-26 |
2009-10-06 |
아이알엠 엘엘씨 |
단백질 키나제 억제제로서의 화합물 및 조성물
|
|
US7605154B2
(en)
|
2005-08-08 |
2009-10-20 |
Janssen Pharmaceutica N.V. |
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
EP1957461B1
(en)
*
|
2005-11-14 |
2016-11-02 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
WO2007076474A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
US20090312396A1
(en)
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
WO2008144253A1
(en)
*
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
|
KR20100058660A
(ko)
|
2007-10-23 |
2010-06-03 |
테바 파마슈티컬 인더스트리즈 리미티드 |
다사티닙 다형체 및 이의 제조 방법
|
|
WO2009076373A1
(en)
|
2007-12-10 |
2009-06-18 |
Concert Pharmaceuticals Inc. |
Heterocyclic kinase inhibitors
|
|
CA2723237A1
(en)
|
2008-05-06 |
2009-11-12 |
Peter A. Blomgren |
Substituted amides, method of making, and use as btk inhibitors
|
|
LT3081552T
(lt)
*
|
2008-08-13 |
2021-06-10 |
Mitsui Chemicals Agro, Inc. |
Kenkėjų kontrolės agentas, turintis amido darinį ir kenkėjų kontrolės agento panaudojimas
|
|
CA2735208A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
MX2012002591A
(es)
|
2009-09-03 |
2012-04-02 |
Allergan Inc |
Compuestos como moduladores de tirosina cinasas.
|
|
WO2011029043A1
(en)
|
2009-09-04 |
2011-03-10 |
Biogen Idec Ma Inc. |
Heteroaryl btk inhibitors
|
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
AU2011328237A1
(en)
|
2010-11-09 |
2013-05-23 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as TYK2 inhibitors
|
|
EP2640366A2
(en)
|
2010-11-15 |
2013-09-25 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
|
LT2714677T
(lt)
*
|
2011-05-23 |
2018-12-10 |
Merck Patent Gmbh |
Piridino ir pirazino dariniai
|
|
US9073947B2
(en)
|
2011-06-10 |
2015-07-07 |
Merck Patent Gmbh |
Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
JP2014528957A
(ja)
*
|
2011-10-03 |
2014-10-30 |
シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト |
殺虫性化合物
|
|
EP2763994A4
(en)
|
2011-10-04 |
2015-08-26 |
Gilead Calistoga Llc |
NEW QUINOXALINE INHIBITORS OF THE PI3K PATH
|
|
TW201326171A
(zh)
|
2011-11-03 |
2013-07-01 |
Genentech Inc |
烷基化哌□化合物
|
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）の阻害剤
|
|
ES2661510T3
(es)
|
2011-12-15 |
2018-04-02 |
Novartis Ag |
Uso de inhibidores de la actividad o función de PI3K
|
|
CN103405429A
(zh)
*
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
USRE50030E1
(en)
|
2013-12-13 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
CA2965178C
(en)
|
2014-10-22 |
2023-09-26 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|